SCHEMBL6881920

SCHEMBL6881920

Clc1ccc2[nH]c3ncnc(Cl)c3c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.56
UTS2R Q9UKP6 1/20 0.47
MAP2K7 O14733 1/20 0.46
ABL1 P00519 2/20 0.46
EGFR P00533 2/20 0.46
ABL2 P42684 1/20 0.46
GSK3B P49841 2/20 0.43
CHEK1 O14757 1/20 0.43
DAPK3 O43293 1/20 0.43
JAK2 O60674 1/20 0.43
MAP4K4 O95819 1/20 0.43
NTRK1 P04629 1/20 0.43
LCK P06239 1/20 0.43
CSF1R P07333 1/20 0.43
RET P07949 1/20 0.43
MET P08581 1/20 0.43
PDGFRB P09619 1/20 0.43
PIM1 P11309 1/20 0.43
FGFR1 P11362 1/20 0.43
PDGFRA P16234 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31219008 1.00 AURKA (0.56) AURKAUTS2RMAP2K7ABL1EGFR
SCHEMBL23885518 0.85 MAP2K7 (0.48) AURKAUTS2RMAP2K7ABL1EGFR
SCHEMBL23852137 0.83 AURKA (0.54) AURKAEGFRGSK3BJAK2ALDH1A1
SCHEMBL7218007 0.80 AURKA (0.65) AURKAEGFRPDGFRBDYRK1AALDH1A1
SCHEMBL6819930 0.80 AURKA (0.50) AURKAEGFRGSK3BCHEK1RET
SCHEMBL31705964 0.80 AURKA (0.50) AURKAEGFRALDH1A1KDM4EMAPT
SCHEMBL30672219 0.79 EGFR (0.57) AURKAABL1EGFRABL2CHEK1
SCHEMBL2389718 0.79 EGFR (0.57) AURKAABL1EGFRABL2CHEK1
SCHEMBL31705582 0.79 AURKA (0.49) AURKAMAP2K7ALDH1A1KDM4EMAPT
SCHEMBL28603330 0.79 AURKA (0.49) AURKAMAP2K7EGFRGSK3BRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024199444-A1 HETEROAROMATIC RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海翊维康医药有限责任公司 2024-10-03 WO disclosed
WO-2011056739-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO disclosed